Skip to main navigation
Nektar Therapeutics
  • About Nektar
    • Our Story
    • Leadership
    • Partnering for Innovation
    • Contact Us
  • Our Pipeline
    • Pipeline
    • Clinical Trials
  • Our Science
    • Scientific Approach
    • Scientific Publications
  • Investors
    • Investor Overview
    • Financials & Filings
    • Press Releases
    • SEC Filings
    • Investor Events
    • Corporate Governance
    • Stock Information
    • Contact IR
    • Historic Stock Lookup
    • Email Alerts
    • Analyst Coverage
  • Our Culture
    • Careers at Nektar
  • For Patients
  • linkedin
Nektar Therapeutics
  • About Nektar
    • Our Story
    • Leadership
    • Partnering for Innovation
    • Contact Us
  • Our Pipeline
    • Pipeline
    • Clinical Trials
  • Our Science
    • Scientific Approach
    • Scientific Publications
  • Investors
    • Investor Overview
    • Financials & Filings
    • Press Releases
    • SEC Filings
    • Investor Events
    • Corporate Governance
    • Stock Information
    • Contact IR
    • Historic Stock Lookup
    • Email Alerts
    • Analyst Coverage
  • Our Culture
    • Careers at Nektar
  • For Patients
  • linkedin
investor relations hero

SEC filing details

Document Details

Form
10-Q
Filing Date
May 9, 2025
Document Date
Mar 31, 2025
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Nektar Therapeutics
Issuer
NEKTAR THERAPEUTICS

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT
Contact IR
Print Page
RSS
Email Alerts
Nektar Therapeutics
  • About Nektar
  • Our Pipeline
  • Our Science
  • Investors
  • Our Culture
  • For Patients
  • linkedin

©2026 Nektar Therapeutics

  • Privacy Policy
  • Terms of Use